Details
Stereochemistry | ACHIRAL |
Molecular Formula | C60 |
Molecular Weight | 720.642 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C12=C3C4=C5C6=C1C7=C8C9=C6C%10=C%11C%12=C9C%13=C%14C%15=C%16C(C%17=C7C2=C%18C%19=C3C%20=C%21C%22=C%19C%23=C%24C(=C%16C%17=C%18%23)C%25=C%15C%26=C%27C%28=C(C%11=C%29C(=C5%10)C(=C4%20)C%30=C%21C%31=C(C%28=C%29%30)C%27=C%25C%24=C%22%31)C%12=C%14%26)=C8%13
InChI
InChIKey=XMWRBQBLMFGWIX-UHFFFAOYSA-N
InChI=1S/C60/c1-2-5-6-3(1)8-12-10-4(1)9-11-7(2)17-21-13(5)23-24-14(6)22-18(8)28-20(12)30-26-16(10)15(9)25-29-19(11)27(17)37-41-31(21)33(23)43-44-34(24)32(22)42-38(28)48-40(30)46-36(26)35(25)45-39(29)47(37)55-49(41)51(43)57-52(44)50(42)56(48)59-54(46)53(45)58(55)60(57)59
Molecular Formula | C60H2 |
Molecular Weight | 722.6579 |
Charge | 0 |
Count |
|
Stereochemistry | MIXED |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome. | 2007 Dec |
|
Gene expression profiles in rat lung after inhalation exposure to C60 fullerene particles. | 2009 Apr 5 |
|
Impact of physicochemical properties of engineered fullerenes on key biological responses. | 2009 Jan 1 |
|
Attenuation of delayed-type hypersensitivity by fullerene treatment. | 2009 Jun 30 |
|
Oxidatively damaged DNA in rats exposed by oral gavage to C60 fullerenes and single-walled carbon nanotubes. | 2009 May |
|
Carbon fullerenes (C60s) can induce inflammatory responses in the lung of mice. | 2010 Apr 15 |
|
Fullerene derivatives induce premature senescence: a new toxicity paradigm or novel biomedical applications. | 2010 Apr 15 |
|
The co-application effects of fullerene and ascorbic acid on UV-B irradiated mouse skin. | 2010 Jan 12 |
|
Photodynamic anticancer activities of water-soluble C(60) derivatives and their biological consequences in a HeLa cell line. | 2012 Jan 5 |
|
Distinct immunomodulatory effects of a panel of nanomaterials in human dermal fibroblasts. | 2012 May 5 |
|
Association of Hg2+ with aqueous (C60)n aggregates facilitates increased bioavailability of Hg2+ in Zebrafish (Danio rerio). | 2013 Sep 3 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 01:26:44 GMT 2023
by
admin
on
Sat Dec 16 01:26:44 GMT 2023
|
Record UNII |
NP9U26B839
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C62379
Created by
admin on Sat Dec 16 01:26:44 GMT 2023 , Edited by admin on Sat Dec 16 01:26:44 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
33416
Created by
admin on Sat Dec 16 01:26:44 GMT 2023 , Edited by admin on Sat Dec 16 01:26:44 GMT 2023
|
PRIMARY | |||
|
DTXSID4031772
Created by
admin on Sat Dec 16 01:26:44 GMT 2023 , Edited by admin on Sat Dec 16 01:26:44 GMT 2023
|
PRIMARY | |||
|
BUCKMINSTERFULLERENE
Created by
admin on Sat Dec 16 01:26:44 GMT 2023 , Edited by admin on Sat Dec 16 01:26:44 GMT 2023
|
PRIMARY | |||
|
123591
Created by
admin on Sat Dec 16 01:26:44 GMT 2023 , Edited by admin on Sat Dec 16 01:26:44 GMT 2023
|
PRIMARY | |||
|
99685-96-8
Created by
admin on Sat Dec 16 01:26:44 GMT 2023 , Edited by admin on Sat Dec 16 01:26:44 GMT 2023
|
PRIMARY | |||
|
33128
Created by
admin on Sat Dec 16 01:26:44 GMT 2023 , Edited by admin on Sat Dec 16 01:26:44 GMT 2023
|
PRIMARY | |||
|
D037741
Created by
admin on Sat Dec 16 01:26:44 GMT 2023 , Edited by admin on Sat Dec 16 01:26:44 GMT 2023
|
PRIMARY | |||
|
C62380
Created by
admin on Sat Dec 16 01:26:44 GMT 2023 , Edited by admin on Sat Dec 16 01:26:44 GMT 2023
|
PRIMARY | NCIT | ||
|
C069837
Created by
admin on Sat Dec 16 01:26:44 GMT 2023 , Edited by admin on Sat Dec 16 01:26:44 GMT 2023
|
PRIMARY | |||
|
NP9U26B839
Created by
admin on Sat Dec 16 01:26:44 GMT 2023 , Edited by admin on Sat Dec 16 01:26:44 GMT 2023
|
PRIMARY | |||
|
m2742
Created by
admin on Sat Dec 16 01:26:44 GMT 2023 , Edited by admin on Sat Dec 16 01:26:44 GMT 2023
|
PRIMARY | Merck Index | ||
|
1435890
Created by
admin on Sat Dec 16 01:26:44 GMT 2023 , Edited by admin on Sat Dec 16 01:26:44 GMT 2023
|
PRIMARY | RxNorm | ||
|
NP9U26B839
Created by
admin on Sat Dec 16 01:26:44 GMT 2023 , Edited by admin on Sat Dec 16 01:26:44 GMT 2023
|
PRIMARY |